ImmuCell Corporation (ICCC)
Add to Watchlists Create an AlertICCC Key Stats
| Income Statement | |
| Revenue TTM | 5.390M |
| Revenue Quarterly YoY Growth | 8.92% |
| EPS Diluted TTM | 0.0244 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | 0.0895M |
| Profitability | |
| Gross Profit Margin Quarterly | 52.80% |
| Profit Margin Quarterly | -1.19% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 11.02M |
| Enterprise Value | 7.377M |
| PE Ratio TTM | 149.55 |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 1.199 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.1379 |
| Free Cash Flow | 0.1372M |
| Return on Equity | 0.97% |
ICCC News
- ImmuCell Announces Increase in Product Sales and Continued Profitability Marketwired May 14
- IMMUCELL CORP /DE/ Files SEC form 8-K, Financial Statements and Exhibits May 14
- IMMUCELL CORP /DE/ Files SEC form 10-K, Annual Report Mar 28
- Cattle-focused biotech ImmuCell sees growth in tough dairy year Feb 14
- IMMUCELL CORP /DE/ Files SEC form 8-K, Financial Statements and Exhibits Feb 14
- ImmuCell Announces Product Sales Increases and Other Financial Results Marketwire Feb 14
- IMMUCELL CORP /DE/ Files SEC form 10-Q/A, Quarterly Report Jan 8
- IMMUCELL CORP /DE/ Files SEC form 10-K/A, Annual Report Jan 8
- Stocks Hitting 52-Week Lows Benzinga Dec 28
- IMMUCELL CORP /DE/ Files SEC form 10-Q, Quarterly Report Nov 13
ICCC Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). ImmuCell Corporation is down 38.64% over the last year vs S&P 500 Total Return up 28.04%, Idexx Laboratories down 2.68%, and Agilent Technologies up 12.35%.
ICCC Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these ICCC related companies
Pro Ratings for ICCC
Pro Report PDF for ICCC
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download ICCC Pro Report PDF
Pro Strategies Featuring ICCC
Did ImmuCell Corporation make it into our Pro Portfolio Strategies?
ICCC Profile
Sector: Healthcare
Industry: Diagnostics & Research
Other ICCC Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ICCC | 3.651 | +0.00 | +0.00% | 11.02M |
